References
- Rossouw J E, Anderson G L, Prentice R L, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
- Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002; 360: 942–944
- Marsden J, A'Hern R. The Million Women Study and breast cancer. J Br Menop Soc 2003; 9: 95–97
- Schneider H PG. Cross-national study of women's use of hormone replacement therapy (HRT) in Europe. Int J Fertil Womens Med 1997; 42(Suppl 2)365–375
- Jolleys J V, Olesen F. A comparative study of prescribing of hormone replacement therapy in USA and Europe. Maturitas 1996; 23: 47–53
- Coo H, O'Connor K S, Hunter D. Women's knowledge of hormone therapy. Patient Educ Couns 2001; 45: 295–301
- Breslau E S, Davis W W, Doner L, et al. The hormone therapy dilemma: women respond. J Am Med Womens Assoc 2003; 58: 33–43
- Pan H A, Wu M H, Hsu C C, Yao B L, Huang K E. The perception of menopause among women in Taiwan. Maturitas 2002; 41: 269–274
- Rolnick S J, Kopher R A, Defor T A, Kelley M E. Hormone use and patient concerns after the findings of the Women's Health Initiative. Menopause 2005; 12: 399–404
- Heitmann C, Greiser E, Doren M. The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany. Menopause 2005; 12: 405–411
- Roberson N L. Clinical trial participation. Viewpoints from racial/ethnic groups. Cancer 1994; 74(Suppl 9)2687–2691
- Safran D G, Taira D A, Rogers W H, Kosinski M, Ware J E, Tarlov A R. Linking primary care performance to outcomes of care. J Fam Pract 1998; 47: 213–220
- Binfa L, Castelo-Branco C, Blumel J E, et al. Influence of psycho-social factors on climacteric symptoms. Maturitas 2004; 48: 425–431
- Blumel J E, Castelo-Branco C, Cancelo M J, et al. Relationship between psychological complaints and vasomotor symptoms during climacteric. Maturitas 2004; 49: 205–210
- Blumel J E, Castelo-Branco C, Riquelme R, et al. Use of hormone replacement therapy among Chilean women: a comparison between socioeconomic levels. Menopause 2002; 9: 377–380
- Strothmann A, Schneider H P. Hormone therapy: the European women's perspective. Climacteric 2003; 6: 337–346
- Blumel J E, Castelo-Branco C, Chedraui P A, et al. Patients' and clinicians' attitudes after the Women's Health Initiative study. Menopause 2004; 11: 57–61
- Hall M A, Dugan E, Zheng B, Mishra A K. Trust in physicians and medical institutions: what is it, can it be measured, and does it matter?. Milbank Q 2001; 79: 613–639
- Rose A, Peters N, Shea J A, Armstrong K. Development and testing of the health care system distrust scale. J Gen Intern Med 2004; 19: 57–63